ERBB2 and breast cancer: We found that the altered group had a higher percentage of aggressive phenotypes, including basal, HER2, and luminal B subtypes, while the unaltered group was enriched for luminal A and normal-like phenotypes (Fig. 7B)This observation suggests that the expression alterations of these genes may be associated with the development and progression of more aggressive subtypes of breast cancer.